Trump administration cuts $766 million in funding to Moderna for bird flu, pandemic vaccine projects

The Trump administration has withdrawn $766 million in funding from Moderna, impacting the development of vaccines against potential pandemic influenza viruses, including H5N1 bird flu. This decision raises concerns despite evidence supporting the safety and efficacy of Moderna's vaccines. Simultaneously, a new, highly contagious Covid-19 variant, NB.1.81, has emerged in the US, adding to public health challenges.